Lipid conjugation of TLR7 agonist Resiquimod ensures...

  • Main
  • 2018 / 10
  • Lipid conjugation of TLR7 agonist Resiquimod ensures...

Lipid conjugation of TLR7 agonist Resiquimod ensures co-delivery with the liposomal Cationic Adjuvant Formulation 01 (CAF01) but does not enhance immunopotentiation compared to non-conjugated Resiquimod+CAF01

Wilkinson, Alexander, Lattmann, Eric, Roces, Carla B., Pedersen, Gabriel, Christensen, Dennis, Perrie, Yvonne
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Journal of Controlled Release
DOI:
10.1016/j.jconrel.2018.10.002
Date:
October, 2018
File:
PDF, 934 KB
english, 2018
Conversion to is in progress
Conversion to is failed